Global Nasal Drug Delivery Systems Overview
Administration of drug trough nasal route is referred as nasal drug delivery system which is an alternative to invasive administrations and provides direct access to systemic circulation. Nasal drug delivery is most preferred route of administration in treatment of allergic and non-allergic rhinitis, nasal congestion, and common cold. Intranasal route can be cross the blood brain barrier and deliver the drug molecules to the central nervous system. The drugs are also been administered via nasal route for therapeutic and recreational purpose, with the help of nasal drug delivery systems. Nasal drug delivery is advisable for drugs undergoing extensive first pass effect. Further, intranasal route is also exploited for bypassing the blood brain barrier and delivery the drugs molecules to the central nervous system. The nasal drug delivery systems are different for different drug, depending on their formation, as liquid nasal preparations are administered through inhalers, droppers, spray pumps, atomizers, or nebulizers. The Global Nasal Drug Delivery Market accounted for US$ 51.20 billion in 2020 and is estimated to be US$ 92.47 billion by 2030 and is anticipated to register a CAGR of 6.1%
Global Nasal Drug Delivery Systems Drivers & Restraints
Increasing awareness regarding nasal drug delivery
The increasing awareness regarding the nasal drug delivery drives the nasal drug delivery systems market. Further, the advantages such as, drug degradation that is observed in gastrointestinal tract is absent, hepatic first pass metabolism is avoided, rapid drug absorption and many more, which increase the adoption of nasal drug delivery systems, in turn propelling the nasal drug delivery market.
Increasing prevalence of diseases
Additionally, with increasing prevalence of diseases is also expected to foster the market of nasal drug delivery systems. For instance, in 2017, according to Journal of Allergy and Clinical Immunology, the prevalence of asthma in developed cities of Asia Pacific such as, Japan, Hong Kong, and Singapore is high as 12.4%.
Furthermore, the technological advancement is also bringing new products into the market. For instance, in 2017, Optinose, an ENT/Allergy specialty pharmaceutical company, received New Drug Application approval for its Xhance, fluticasone propionate, for the indication of nasal polyps in adults.
Global Nasal Drug Delivery Systems Segmentations & Regional Insights
Global nasal drug delivery systems market is segmented on the basis of dosage form, container type, system type, therapeutic application, distribution channel, and region.
On the basis of dosage form, the global nasal drug delivery systems market is categorized into nasal spray, nasal drops, nasal gels, nasal powders, and others. On the basis of system type, the target market is segmented into multi-dose, bi-dose, and unit dose. On the basis of therapeutic applications, the target market is segmented into allergic and non-allergic rhinitis, nasal congestion, vaccination, and others. On the basis of distribution channel, the global nasal drug delivery system is categorized into market hospitals pharmacies, retail pharmacies, and online pharmacies.
Regional Insights:
For detailed understanding of market dynamics, On the basis of region, the global nasal drug delivery system market has been segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. The market in North America is expected to account for major revenue share as compared to that of other regions. This can be attributed to rising research and development by local manufacturers to develop new drug device or delivery system combination. Also, the market in Europe is expected to account for second-highest revenue share in the global market, followed by the market in Asia Pacific.
|
Attribute |
Details |
|
Base year for estimation |
2020 |
|
Forecast period |
2020 – 2030 |
|
Market representation |
Revenue in USD Million & CAGR from 2020 – 2030 |
|
Market Segmentation |
By Dosage Form- Nasal Spray, Nasal Drops, Nasal Gels, Nasal Powders, And Others By Container Type- Non-Pressurized and Pressurized Container By System Type- Multi-Dose, Bi-Dose, And Unit Dose By Therapeutic Application- Allergic And Non-Allergic Rhinitis, Nasal Congestion, Vaccination, And Others By Distribution Channel- Hospitals Pharmacies, Retail Pharmacies, And Online Pharmacies. |
|
Regional scope |
North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa |
|
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors, and trends |
Detailed Segmentation:
Global Nasal Drug Delivery Systems Market, By Dosage Form:
- Nasal Spray
- Nasal Drops
- Nasal Gels
- Nasal Powders
- Others
Global Nasal Drug Delivery Systems Market, Container Type:
- Non-pressurized Containers
- Pressurized Containers
Global Nasal Drug Delivery Systems Market, By System Type:
- Multi-dose
- Bi-dose
- Unit dose
Global Nasal Drug Delivery Systems Market, By Therapeutic Application:
- Allergic and Non-allergic Rhinitis
- Nasal Congestion
- Vaccination
- Others
Global Nasal Drug Delivery Systems Market, By Distribution Channel:
- Hospitals Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Nasal Drug Delivery Systems Market, By Region:
o North America
- North America Nasal Drug Delivery Systems Market, By Dosage Form
- North America Nasal Drug Delivery Systems Market, By Container Type
- North America Nasal Drug Delivery Systems Market, By System Type
- North America Nasal Drug Delivery Systems Market, By Therapeutic Application
- North America Nasal Drug Delivery Systems Market, By Distribution Channel
- North America Nasal Drug Delivery Systems Market, By Country
- U.S.
- Canada
o Europe
- Europe Nasal Drug Delivery Systems Market, By Dosage Form
- Europe Nasal Drug Delivery Systems Market, By Container Type
- Europe Nasal Drug Delivery Systems Market, By System Type
- Europe Nasal Drug Delivery Systems Market, By Therapeutic Application
- Europe Nasal Drug Delivery Systems Market, By Distribution Channel
- Europe Nasal Drug Delivery Systems Market, By Country
- Germany
- UK
- France
- Russia
- Italy
- Switzerland
- Sweden
- Rest of Europe
o Asia-Pacific
- Asia-Pacific Nasal Drug Delivery Systems Market, By Dosage Form
- Asia Pacific Nasal Drug Delivery Systems Market, By Container Type
- Asia-Pacific Nasal Drug Delivery Systems Market, By System Type
- Asia-Pacific Nasal Drug Delivery Systems Market, By Therapeutic Application
- Asia-Pacific Nasal Drug Delivery Systems Market, By Distribution Channel
- Asia-Pacific Nasal Drug Delivery Systems Market, By Country
- China
- India
- Australia & New Zealand
- Japan
- South Korea
- Rest of Asia Pacific
o Latin America
- Latin America Nasal Drug Delivery Systems Market, By Dosage Form
- Latin America Nasal Drug Delivery Systems Market, By Container Type
- Latin America Nasal Drug Delivery Systems Market, By System Type
- Latin America Nasal Drug Delivery Systems Market, By Therapeutic Application
- Latin America Nasal Drug Delivery Systems Market, By Distribution Channel
- Latin America Nasal Drug Delivery Systems Market, By Country
- Brazil
- Mexico
- Argentina and Chile
- Rest of Latin America
o Middle East
- Middle East Nasal Drug Delivery Systems Market, By Dosage Form
- Middle East Nasal Drug Delivery Systems Market, By Container Type
- Middle East Nasal Drug Delivery Systems Market, By System Type
- Middle East Nasal Drug Delivery Systems Market, By Therapeutic Application
- Middle East Nasal Drug Delivery Systems Market, By Distribution Channel
- Middle East Nasal Drug Delivery Systems Market, By Country
- GCC
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East
o Africa
- Africa Nasal Drug Delivery Systems Market, By Dosage Form
- Africa Nasal Drug Delivery Systems Market, By Container Type
- Africa Nasal Drug Delivery Systems Market, By System Type
- Africa Nasal Drug Delivery Systems Market, By Therapeutic Application
- Africa Nasal Drug Delivery Systems Market, By Distribution Channel
- Africa Nasal Drug Delivery Systems Market, By Country
- North Africa
- Central Africa
- South Africa
Global Nasal Drug Delivery Systems Competitive Landscape & Key Players
Key players operating in the global nasal drug delivery system market Merck & Co., GlaxoSmithKline plc., AstraZeneca plc., Johnson & Johnson, Pfizer Inc., Baxter International, Inc., Valeant Pharmaceuticals International, Inc., Becton, Dickinson and Company, and Novartis AG. For Instance, in 2019, Aptar Pharma, a leading drug delivery systems provider, is pleased to announce that its Bidose nasal spray device was recently approved by the U.S. FDA for a breakthrough therapy in the field of depression. This marks the first FDA approval and U.S. launch of a prescription drug using Aptar Pharma’s patented Bidose nasal spray delivery system.
Global Nasal Drug Delivery Systems Company Profile
o Merck & Co.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Business Strategy Overview
o GlaxoSmithKline plc
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Business Strategy Overview
- AstraZeneca plc
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Business Strategy Overview
- Johnson & Johnson
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Business Strategy Overview
- Pfizer Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Business Strategy Overview
- Baxter International, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Business Strategy Overview
- Valeant Pharmaceuticals International, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Business Strategy Overview
- Becton, Dickinson and Company
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Business Strategy Overview
- Novartis AG
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Business Strategy Overview
Global Nasal Drug Delivery Systems Highlights
FAQs
The global digital payment solutions market report segments the market on the basis of type, application, and region.
Contactless payments help reduce customer queues and hassles, and supply better leads to the shape of upper revenue for retailers.
Asia-Pacific has the largest market in terms of revenue due to increasing proliferation of smartphones enabling e-commerce and rise in the ecommerce sales and growth in internet penetration in this region.
Some of the prominent players operating in the global digital payment solutions market include First Data Corp, Worldpay Inc., Chetu, Paypal, Wirecard, Fiserv, Total System Services (TSYS), Novatti, Global Payments, and Bluesnap.